Akzo Nobel N.V.
AKZOF
$63.59
-$7.90-11.05%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.98B | 2.98B | 2.75B | 2.79B | 2.93B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.98B | 2.98B | 2.75B | 2.79B | 2.93B |
| Cost of Revenue | 1.78B | 1.80B | 1.65B | 1.70B | 1.74B |
| Gross Profit | 1.20B | 1.18B | 1.10B | 1.09B | 1.19B |
| SG&A Expenses | 906.06M | 928.37M | 891.34M | 635.32M | 892.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 319.17M | -2.27M | 1.05M | 1.07M | 5.50M |
| Total Operating Expenses | 3.00B | 2.73B | 2.54B | 2.65B | 2.64B |
| Operating Income | -24.55M | 251.95M | 210.47M | 141.77M | 292.43M |
| Income Before Tax | -112.23M | 203.15M | 177.85M | 101.27M | 271.55M |
| Income Tax Expenses | 109.90M | 49.94M | 50.51M | 62.89M | 84.65M |
| Earnings from Continuing Operations | -222.13M | 153.22M | 127.33M | 38.37M | 186.89M |
| Earnings from Discontinued Operations | -1.17M | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.51M | -12.48M | -14.73M | -15.99M | -7.70M |
| Net Income | -226.81M | 140.73M | 112.60M | 22.39M | 179.20M |
| EBIT | -24.55M | 251.95M | 210.47M | 141.77M | 292.43M |
| EBITDA | 85.35M | 356.37M | 309.39M | 241.97M | 397.97M |
| EPS Basic | -1.33 | 0.82 | 0.66 | 0.13 | 1.05 |
| Normalized Basic EPS | -0.41 | 0.67 | 0.56 | 0.27 | 0.94 |
| EPS Diluted | -1.33 | 0.82 | 0.65 | 0.13 | 1.04 |
| Normalized Diluted EPS | -0.41 | 0.67 | 0.56 | 0.26 | 0.94 |
| Average Basic Shares Outstanding | 171.00M | 171.00M | 170.80M | 170.80M | 170.80M |
| Average Diluted Shares Outstanding | 171.00M | 171.00M | 172.58M | 175.00M | 171.58M |
| Dividend Per Share | 0.51 | -- | -- | 1.64 | 0.00 |
| Payout Ratio | -13.92% | 216.94% | 5.61% | 247.62% | 3.07% |